| Overview |
| bs-5156R-Cy3 |
| phospho-LSP1 (Ser252) Polyclonal Antibody, Cy3 Conjugated |
| WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic phosphopeptide derived from human LSP1 around the phosphorylation site of Ser252 |
| Ser252 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 4046 |
| Cytoplasm, Cell membrane |
| 47 kDa actin binding protein; 47 kDa actin-binding protein; 52 kDa phosphoprotein; F actin binding and cytoskeleton associated protein; Leufactin leukocyte F-actin binding protein; Leufactin; Leukocyte F actin binding protein; Leukocyte specic protein 1; LSP 1; Lsp1; LSP1_HUMAN; Lymphocyte specic antigen WP34; Lymphocyte specic protein 1; Lymphocyte specic protein pp52; Lymphocyte-specic antigen WP34; Lymphocyte-specic protein 1; OTTHUMP00000014138; OTTHUMP00000014139; OTTHUMP00000014140; OTTHUMP00000069612; OTTHUMP00000069614; OTTHUMP00000069615; OTTHUMP00000069616; pp52; Protein pp52; S37 protein; WP 34; WP34. |
| May play a role in mediating neutrophil activation and chemotaxis. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz